This page is part of the PACIO Personal Functioning and Engagement Implementation Guide (v2.0.0-ballot: STU 2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: PFEIG-AllergyACE - XML Representation

Raw xml | Download

<AllergyIntolerance xmlns="http://hl7.org/fhir">
  <id value="PFEIG-AllergyACE"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-allergyintolerance"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AllergyIntolerance PFEIG-AllergyACE</b></p><a name="PFEIG-AllergyACE"> </a><a name="hcPFEIG-AllergyACE"> </a><a name="PFEIG-AllergyACE-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}">Active</span></p><p><b>verificationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}">Confirmed</span></p><p><b>category</b>: Medication</p><p><b>criticality</b>: High Risk</p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 372733002}">Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)</span></p><p><b>patient</b>: <a href="Patient-PFEIG-patientBSJ1.html">Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)</a></p><p><b>asserter</b>: <a href="Patient-PFEIG-patientBSJ1.html">Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)</a></p><p><b>lastOccurrence</b>: 2011-10</p><h3>Reactions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Substance</b></td><td><b>Manifestation</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 308963}">captopril 12.5 MG Oral Tablet</span></td><td><span title="Codes:{http://snomed.info/sct 427195008}">Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)</span></td></tr></table></div>
  </text>
  <clinicalStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"/>
      <code value="active"/>
    </coding>
  </clinicalStatus>
  <verificationStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"/>
      <code value="confirmed"/>
    </coding>
  </verificationStatus>
  <category value="medication"/>
  <criticality value="high"/>
  <code>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="372733002"/>
      <display
               value="Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)"/>
    </coding>
  </code>
  <patient>🔗 
    <reference value="Patient/PFEIG-patientBSJ1"/>
  </patient>
  <asserter>🔗 
    <reference value="Patient/PFEIG-patientBSJ1"/>
  </asserter>
  <lastOccurrence value="2011-10"/>
  <reaction>
    <substance>
      <coding>
        <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
        <code value="308963"/>
        <display value="captopril 12.5 MG Oral Tablet"/>
      </coding>
    </substance>
    <manifestation>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="427195008"/>
        <display
                 value="Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)"/>
      </coding>
    </manifestation>
  </reaction>
</AllergyIntolerance>